NFKB1 and neoplasm: Since NFκB is a master regulator of the inflammatory response, survival, and tumor proliferation [26], and a known mediator of pathway indifference [27], NFκB activation at the 48-h time point may represent a common kinome adaptation that is agnostic to the MPNST genomic context.